References
- 1. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 1996; 9: 458-60.
- 2. Northeim KB, Jonssopn G, Omdal R. Biological mechanisms of chronic fatigue. Rheumatology (Oxf) 2011; 50: 1009-18.
- 3. Stone P, Richards M, A’Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 2000; 11: 561-7.
- 4. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449-55.
- 5. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988; 45:435-7.
- 6. Van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxf) 2010; 49: 1294-302.
- 7. Tench CM, McCurdie I, White PD, D’Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxf)2000; 39: 1249-54.
- 8. Bjerrum K, Prause JU. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol 1990; 8:283-8.
- 9. Reese JA, Newton J, Watson S, et al. Documentation of fatigue in patients with immune thrombocytopenic purpura (ITP) and its association with autonomic dysfunction. Blood (ASH Annual Meeting Abstracts) 2010; 116: 570.
- 10. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue Severity Scale. Arch Neurol 1989; 46: 1121-3.
- 11. Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurological disability. Mult Scler 2000; 6:181-5.
- 12. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psych 1961; 4: 561-71.
- 13. Kroenke K, Wood D, Mangelsdorff D, Meier N, Powell J. Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 1988; 260: 929-34.
- 14. David A, Pelosi A, McDonald E, et al. Tired, weak or in need of rest: fatigue among general practice attenders. BMJ 1990; 301:1199-222.
- 15. Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific northwest health care system. Ann Int Med 1995; 123: 81-8.
- 16. Giles I, Isenberg D. Fatigue in primary Sjogren’s syndrome: Is there a link with the fibromyalgia syndrome? Ann Rheum Dis 2000; 59: 875-8.
- 17. Strober LB, Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 631-46.
- 18. Zivancevic-Simonovic S, Djukic A, Arsenijevic N, Dimitrijevic Lj. Autoimunska bolest štitaste žlezde:patogeneza Gravesove bolesti i Hashimoto tireoiditisa. Medicus 2003; 4: 21-6.
- 19. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem 2006; 43: 173-83.
- 20. McLachlan SM, Nagayama Y, Pichurin PN, et al. The link between Graves’ disease and Hashimoto’s thyroiditis: A role for regulatory T cells. Endocrinology 2007; 148: 5724-33.
- 21. Zonana-Nacach A, Roseman JM, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. Lupus 2000; 9:101-9.
- 22. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol 1998; 25: 892-5.
- 23. Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz M. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 379-81.
- 24. Farracci F, Carnevale A. The neurological disorder associated with thyroid autoimmunity. J Neurol 2006; 253: 975-84.
- 25. Miletic-Drakulic S, Toncev G, Vrndic O, Zivancevic-Simonovic S. Neurological symptoms and signs in patients with autoimmune thyroid disease. Serbian Journal of Experimental and Clinical Research 2011; 12: 123-6.
- 26. Hall RCW, Popkin MK, DeVaul R. Psychiatric manifestations of Hashimoto’s thyroiditis. Psychosom 1982; 23: 337-42.
- 27. Kramer CK, von Muhlen D, Kritz-Silverstein D, Barrett- Connor E. Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol 2009; 161: 917-21.
- 28. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998; 158: 1413-8.
- 29. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006; 91: 145-53.
- 30. Louwerens M, Appelhof BC, Verloop H, et al. Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism. Eur J Endocrinol 2012; 167(6): 809-15.
- 31. Pop VJ, Maartens LH, Leusink G, et al. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 1998; 83: 3194-7.
- 32. Vercoulen JH, Hommes OR, Swanink CM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with chronic fatigue syndrome and healthy subject. Arch Neurol 1996; 53:642-9.
- 33. Moller A, Weidemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment anddepressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 1994; 89: 117-21.
- 34. Koroecke DC, Lynch SG, Denney DR. Fatigue in multiple sclerosis: relationship to depression, disability and disease pattern. Mult Scler 2000; 6:131-6.
- 35. Iriarte J, Subira ML, Castro P. Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler 2000; 6: 124-30.